Alginate-iron speciation and its effect on in vitro cellular iron metabolism by Horniblow, Richard D. et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1371/journal.pone.0138240
Document Version
Publisher's PDF, also known as Version of record
Link to publication record in King's Research Portal
Citation for published version (APA):
Horniblow, R. D., Dowle, M., Iqbal, T. H., Latunde-Dada, G. O., Palmer, R. E., Pikramenou, Z., & Tselepis, C.
(2015). Alginate-iron speciation and its effect on in vitro cellular iron metabolism. PL o S One , 10(9),
[e0138240]. DOI: 10.1371/journal.pone.0138240
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 06. Nov. 2017
RESEARCH ARTICLE
Alginate-Iron Speciation and Its Effect on In
Vitro Cellular Iron Metabolism
Richard D. Horniblow1, Miriam Dowle2, Tariq H. Iqbal1, Gladys O. Latunde-Dada3, Richard
E. Palmer2, Zoe Pikramenou4☯, Chris Tselepis1☯*
1 University of Birmingham, School of Cancer Sciences, College of Medical and Dental Sciences, Vincent
Drive, Edgbaston, Birmingham, B15 2TT, United Kingdom, 2 University of Birmingham, School of Physics,
College of Engineering and Physical Sciences, Edgbaston, Birmingham, B15 2TT, United Kingdom,
3 Diabetes and Nutritional Sciences, King's College London, Franklin Wilkins Building, 150 Stamford Street,
London, SE1 9NH, United Kingdom, 4 University of Birmingham, School of Chemistry, College of
Engineering and Physical Sciences, Edgbaston, Birmingham, B15 2TT, United Kingdom
☯ These authors contributed equally to this work.
* c.tselepis@bham.ac.uk
Abstract
Alginates are a class of biopolymers with known iron binding properties which are routinely
used in the fabrication of iron-oxide nanoparticles. In addition, alginates have been impli-
cated in influencing human iron absorption. However, the synthesis of iron oxide nanoparti-
cles employs non-physiological pH conditions and whether nanoparticle formation in vivo is
responsible for influencing cellular iron metabolism is unclear. Thus the aims of this study
were to determine how alginate and iron interact at gastric-comparable pH conditions and
how this influences iron metabolism. Employing a range of spectroscopic techniques under
physiological conditions alginate-iron complexation was confirmed and, in conjunction with
aberration corrected scanning transmission electron microscopy, nanoparticles were
observed. The results infer a nucleation-type model of iron binding whereby alginate is
templating the condensation of iron-hydroxide complexes to form iron oxide centred nano-
particles. The interaction of alginate and iron at a cellular level was found to decrease cellu-
lar iron acquisition by 37% (p < 0.05) and in combination with confocal microscopy the
alginate inhibits cellular iron transport through extracellular iron chelation with the resulting
complexes not internalised. These results infer alginate as being useful in the chelation of
excess iron, especially in the context of inflammatory bowel disease and colorectal cancer
where excess unabsorbed luminal iron is thought to be a driver of disease.
Introduction
Alginates are a diverse class of biopolymers extracted from brown algae that are composed of
1–4 linked β-D-mannuronic acid (M) and α-L-guluronic acid (G) monomers. The polymers
can vary in both chain length and composition which, in conjunction with their ability to inter-
act with divalent metal cations, endows alginates with a wide range of physicochemical proper-
ties. Thus unsurprisingly alginates are widely used in the food industry, primarily due to their
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gelling capacity, and are also used in a range of medical applications, for example, in wound-
healing preparations[1], controlled drug release systems[2,3] and anti-reflux formulations.[4]
In addition, alginates are used for the construction of iron-oxide nanoparticles which have a
myriad of applications from drug delivery to magnetic resonance imaging.[5]
The use of alginate as a scaffold for nanoparticle formulation is a well-accepted synthetic
strategy, however, in these reactions the iron-oxide nanoparticles are fabricated using chemi-
cal-forcing conditions whereby highly basic conditions are used to form the iron hydroxide.[5–
8] These conditions are considered optimal for the formation of iron oxide nanoparticles, with
mean diameters ranging between 9 to 10 nm.[9,10] However, whether these iron oxide nano-
particles can form spontaneously in the gastrointestinal tract of man and in particular at low
pH conditions of the stomach, (the first reasonable site of interaction between iron and alginate
consumed in the diet) is unknown.
Supporting the concept of alginate binding iron, there is an increasing body of evidence
emerging that alginates impact on iron metabolism in man.[11,12] A recent human study iden-
tified that an alginate supplemented diet resulted in decreased serum iron levels, alluding to the
role of alginates chelating iron and thus limiting its absorption in the small bowel.[12] On the
contrary, cellular studies have previously shown alginate as having an enhancing effect on
intracellular iron concentration as assessed by ferritin expression; a surrogate biomarker for
cellular iron levels.[13] However, whether these observed changes in cellular iron metabolism
are related to the formation of alginate-iron nanoparticles is unknown. Interestingly, iron-
oxide nanoparticles have been studied with respect to their cellular uptake with a potential
application in iron fortification to treat anaemia.[14–16] No toxicity was associated with the
uptake of these nanoparticles and results indicated that these Fe(III) nanoparticles were
directly taken up by enterocytes in vitro and markedly increased cellular iron concentrations.
Thus, the existing published literature is inconsistent and it remains unclear how alginates
might interact with iron in the context of the gut and whether any resulting complexation may
be of use as a platform for iron fortification or chelation.
Therefore, the aims of this study are i) to determine how alginate and iron(III) interact at
gastric-comparable pH conditions; ii) to verify the speciation of iron with alginate upon com-
plexation under these conditions and iii) to understand how alginate modulates cellular iron
status.
Materials and Methods
Alginate preparation
Sodium alginate LFR5/60 was a kind gift of FMC Biopolymer, Norway. The average molecular
weight is 34700 Da and a G/M composition of 65%/35%. Dispersion of alginates into water
was achieved through high vortex stirring and solutions left overnight to ensure full hydration.
Isothermal Titration Calorimetry
An adapted protocol was used whereby iron was titrated into LFR5/60 at 37°C.[17] Isothermal
Titration Calorimetry (ITC) measurements were performed on a VPITC MicroCalorimeter
and data was automatically analysed using MicoCal LLC ITC/Origin software package; the
binding isotherm was obtained by integrating injections and fitting them to an appropriate
binding model. All alginate solutions were excessively dialysed before use, to eliminate errors
caused by pH and ionic strength mismatches, and also degassed before use at 2°C below the
titration temperature. Typical experimental parameters included: 37°C cell temperature,
10 μcal s-1 reference power, stirring speed at 286 rpm with the initial injection being small
(2 μl) and discarded in the data analysis. Titration was performed by injection of 8 μl aliquots
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of aqueous iron (III) chloride (5mM) in DI H2O into a solution of aqueous LFR5/60 (0.07 mM,
pH = 5.8) in DI H2O. A delay of 350 sec between each injection was set to allow the energy dif-
ference to return back to baseline. To account for the high energy changes associated with iron
titration into water (the control titration), these heat integrations were subtracted from that of
the alginate-iron titration and the subsequent heats of interaction were fitted using a model of
two binding sites.
Equilibrium dialysis preparation of alginate-iron composites
Alginate solutions (0.1% w/v, 10 ml) were sealed into a dialysis membrane (Mr cut off = 12,400
Da) and incubated in aqueous FeCl36H2O (10 mM, 750 ml) for 120 min and washed in deio-
nised water for a subsequent 120 min. The pH changes of the alginate were tracked over the
period of the incubation. The pH of the alginate inside the dialysis bag pre-incubation was
5.8 and the pH of iron solution pre incubation was 1.7, equivalent to gastric acidity.[18] The
pH of the alginate after incubation was 1.9 and after the wash period this was 3.7.
UV-visible spectroscopy
Absorption spectra were recorded on a Varian Cary50 spectrometer using a quartz cuvette,
path length 1 cm. Increments of varying volumes of aqueous FeCl36H2O (10mM) in DI H2O
were titrated into a stirred solution of aqueous alginate (2 mL, 0.1% w/v) in DI H2O, allowed to
equilibrate for several seconds and then scanned. Measurements were taken up to a point of
saturation. To correct for the absorption of aqueous-iron species at the wavelengths of interest
difference absorbance spectra were obtained by correction of the alginate titration with the
equimolar iron-water control titration.
CD-spectroscopy
CDmeasurements were recorded on a Jasco J-810 CD spectropolarimeter (4 accumulations
with 1 s response) using a 1cm path length, blackened quartz cell. Samples for CD measure-
ments were prepared as described for the dialysis preparations above.
Cell culture
Human RKO colorectal carcinoma cells (obtained from the ACTT CRL-2577) were routinely
cultured in Dulbecco’s modified eagles medium including 10% v/v foetal calf serum, 100 units/
ml penicillin and 0.1 mg/ml streptomycin. Cells were seeded in six well plates at a concentra-
tion of 1x105 cells/ml and grown in medium alone for 24 hours. Once established, the growth
medium was removed and supplemented medium was added (Iron loaded medium: 100 μM
FeSO47H2O and 10 μM sodium ascorbate or alginate loaded medium: LFR5/60 (0.3% (w/v)),
100 μM FeSO47H2O and 10 μM sodium ascorbate)) and incubated for 24 hours. Preparation
of these media was performed as follows; aqueous FeSO47H2O (100 μL, 10 mM) containing
sodium ascorbate (500 mM) in DI H2O was added to a sample of aqueous sodium alginate
(1.5 mL, 2% w/v) in DI H2O and mixed. Growth medium was then added (8.4 mL) and all
constituents were thoroughly mixed. Where alginate was not supplemented, growth medium
(9.9 mL) was added to the iron only. After 24 hours the medium was removed and the cells
washed three times with phosphate buffered saline (PBS). Cells were lysed on ice in RIPA
buffer (nonyl phenoxypolyethoxylethanol 1% (v/v), sodium deoxycholate 0.5% (w/v) and
sodium dodecyl sulphate 0.1% (w/v)) containing protease inhibitors. All samples were then
sonicated for 10 sec whilst kept at 4°C. A protein assay kit (Peirce BCA protein assay) was used
to determine the protein concentration in each sample.
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Western blotting
Western blotting was performed as previously described, with monoclonal antibodies to ferri-
tin (1:5000, Abcam, Rabbit AB69090) and β-actin (1:5000, Abcam, Mouse AB8226).[19] All
blots were subject to densitometry analysis using ImageJ analysing software and data normal-
ised to respective β-actin loading controls.
Synthesis of FITC-alginate
Synthesis of FITC-alginate was performed according to the protocol of Strand et al. [20]
Sodium alginate LFR5/60 (0.32 g, 9.2X10-6 moles) was dissolved in a solution of phosphate
buffered saline at pH 7.4 (50 ml). 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide) (0.018 g,
9.2X10-5 moles) and n-Hydroxysulfosuccinimide sodium salt (0.02 g, 9.2X10-5 moles) was
added to the alginate solution and stirred for two hours. Once mixed, fluoresceinamine
(0.0319 g, 9.2X10-5 moles) was added and the reaction left to stir in darkness for 24 hours. Free,
unreacted fluorophore was removed by extensive dialysis; one wash in deionised H2O (3.5 L) at
4°C for 24 hours, three washes in NaCl (3.5 L, 1 M) for 24 hours each, then a subsequent six
washes in deionised H2O (3.5 L) for 24 hours each. Once purified, the pH of the solution was
adjusted to 7.4 and stored in the dark at 4°C until required.
Confocal microscopy
Slides for confocal microscopy were prepared by growing RKO cells on sterile 22 mm cover
slips placed in individual wells of a six well cell culture plate. Cells were seeded in six well plates
at a concentration of 1X105 cells/ml and grown in medium alone for 24 hours. Once estab-
lished, cell permeabilisation was performed using saponin (50 μg/ ml) as previously described.
[21] The growth medium was replaced with fluorescent-alginate loaded medium (0.04% fluo-
rescent alginate, 100 μM FeSO47H2O and 10 μM sodium ascorbate) and incubated for 24
hours. Cell nuclei and plasma membranes were subsequently stained with Hoechst 33450
(NucBlue Live Cell Stain, Life technologies) and CellMask Deep Red plasma stain, (Life tech-
nologies) respectively and cells fixed with a 4% paraformaldehyde solution (pH 7.4) at room
temperature. Once fixed images were captured using a Zeiss LSM510 META confocal system
with x63 1.4 oil immersion objective.
Intracellular iron assessment
Cells were seeded in six well plates at a concentration of 1X105 cells/ml and grown in medium
alone for 24 hours. Once established, the growth medium was removed and supplemented
medium was added (Iron loaded medium: 100 μM FeSO47H2O and 500 μM sodium ascorbate,
or alginate loaded medium: LFR5/60 (0.3% (w/v)), 100 μM FeSO47H2O and 500 μM sodium
ascorbate)) and incubated for 24 hours; in both instances iron stimulations were spiked with
59FeCl3 to reach ca. 10,000 counts per minute (CPM) per well. To prepare the radio-active iron
medium with alginate, aqueous FeSO47H2O (100 μL, 10 mM) in DI H2O containing sodium
ascorbate (500 mM) in DI H2O was mixed with
59FeCl3 in aqueous HCl (0.1M). This was then
added to aqueous sodium alginate (1.5 mL, 2% w/v) in DI H2O and thoroughly mixed. Growth
medium was then added (8.4 mL) and all constituents mixed. In iron-only supplemented
media, no sodium alginate was added, only the addition of growth medium (9.9 mL) to the
radio-active iron. After this incubation period the medium was removed and cells washed
three times with 2 ml Versene (0.2g/L EDTA in phosphate buffered saline), and lysed in 150 μl
HEPES-saline lysis buffer (10 mM, pH 7.4, NaCl 0.9% (w/v)). To determine cellular iron
content, the lysates were pipetted into scintillation tubes containing scintillation fluid (1 mL,
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PerkinElmer OPTIPHASE HISAFE3) and counted on a gamma-counter (Packard 2500 TR liq-
uid scintillation counter).
Scanning Transmission Electron Microscopy/ Energy-dispersive X-ray
spectroscopy
Alginate-iron samples used for STEM/EDX were made using the equilibrium dialysis tech-
nique as described earlier. Preparation of these samples was performed as follows; aqueous
sodium alginate (10 mL, 0.1% w/v, pH 5.8) in DI H2O was sealed within a dialysis membrane
and immersed in a pre-mixed solution of FeCl36H2O (10 mM, 750 ml, pH 1.7) for 120 min.
The dialysis bag was removed, and subsequently immersed in pure DI H2O (750 mL) and incu-
bated for another 120 min. Due to the viscous nature of the sample, copper TEM grids coated
with lacey carbon were loaded with 50 μl of sample and excess sample was drawn from under-
neath, effectively pulling the sample through the grid. This produced a thin sample coverage
over the grid with many sampling areas.
Electron microscopy images were taken using a 200kV FEG Jeol 2100F scanning transmis-
sion electron microscope fitted with a CEOS aberration corrector. Images were simultaneously
acquired in high angular annular dark field (HAADF) and bright field (BF) mode using the
Gatan DigitalMicrograph software package.
Results
Studies of iron-alginate complexation
Isothermal titration microcalorimetry (ITC) was performed to examine the strength of interac-
tion between iron and alginate (LFR5/60). Iron(III) chloride was titrated into a solution of
LFR5/60 and a drop in the integrated heats of each addition was observed (Fig 1A) Saturation
of iron binding by alginate occurred at a molar ratio of iron:alginate of 3:1, with a 5 times
excess of iron used to ensure saturation of all the binding sites on the alginate. Data analysis,
which was best fit using a two-site binding model, revealed two binding events between alginate
and iron with the estimated binding constants calculated as K1 = 1X10
6 and K2 = 3X10
4 M-1
respectively. The equation that models this binding can be found in S1 Fig. Entropy was posi-
tive in both binding events (18.4 and 23.2 cal mol-1 K-1). Enthalpy values were found to be exo-
thermic for both binding events (-704 x 104 and -1548 cal mol-1).
The binding of ferric ions to alginate was further verified using UV-Visible and Circular
Dichroism (CD) spectroscopy. (Fig 1B and 1C) Titration of an aqueous solution of Fe(III) to
an aqueous solution of sodium alginate LFR5/60 revealed the growth of a band at 280 nm
(Fig 1C); confirming iron binding to alginate. Profile changes were plotted against molar equiv-
alents of iron and a binding plot for alginate iron binding was obtained (Fig 1B). This data can
be fitted to a 1:1 binding equation and an alginate iron binding constant of K = 1X103 M-1 cal-
culated (S2 Fig).
To further support the spectroscopic results demonstrating alginate complexation, CD spec-
troscopy was also performed since its fundamental application is probing transitions within
chiral compounds; alginate is highly chiral due to its polymeric nature and the chiral carbon
centres on the individual monomers. Alginate-iron complexes were isolated using equilibrium
dialysis. The CD spectrum of the isolated iron-alginate complexes shows the appearance of a
peak at 280 nm (Fig 1C), which correlates with the peak identified in the UV-visible spectrum
(Fig 1B). This profile is indicative of iron hydroxide (Fe-OH) binding and confirms that the
changes observed in the UV-visible spectrum are attributed to the alginate binding to Fe-OH
species in solution (Fig 1C).
Alginate Modulation of Iron Metabolism
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Fig 1. Chemical analysis of iron alginate binding. (Ai) Isothermal titration microcalorimetry thermogram of 8 μl injectants of 5 mM Fe(III) into 0.04 mM
alginate at 37°C. (Aii) Corresponding isotherm. (Bi) UV-Visible difference spectra of iron (III) titrated into alginate with a clear absorbance change at ca. 280
nm (Bii) absorbance change at 274nm vs final Fe concentration (M) with binding curve) (C) CD spectra of alginate-iron composites isolated via equilibrium
dialysis. An induced CD signal is evident at ca. 280 nm. This correlates to the iron-hydroxide species bonded to the alginate as indicated from the UV-Visible
spectra.
doi:10.1371/journal.pone.0138240.g001
Alginate Modulation of Iron Metabolism
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Alginates template iron oxide nanoparticle formation under simple
mixing conditions
As CD identified the presence of Fe-OH within the alginate-iron composites, these were fur-
ther characterised using aberration corrected STEM (Fig 2). This is capable of achieving ultra-
high resolution with atomic number contrast imaging in the material sciences, but is rarely
used to investigate ‘biological’ samples due to the low atomic number of most bio-materials.
[22] However, the iron component of the alginate-iron composites provided distinguishable
contrast, thus it was possible to image atomic structure at the highest resolution (Fig 2).
Low magnification HAADF-STEM imaging revealed a gel-like alginate network covered in
iron with dense nucleation-sites present (Fig 2A) while energy-dispersive X-ray spectroscopy
confirmed that these dense centres indeed contained iron (Fig 2C). Within this gel, small nano-
particles with a mean diameter of 1.78 ± 0.70 nm were detected and under higher magnifica-
tion lattice structures could be visualised within these nanoparticles (Fig 2B). Fast Fourier
transform analysis of the lattice arrangements gave diffraction spots (labelled) which were in
partial agreement with both Fe2O3 hematite, and ferrihydrite, but the small particles yielded
insufficient visible bright spots to determine the precise phase of these nanoparticles.[6,23]
Samples of aqueous iron chloride alone were imaged and there was no evidence of particulate
iron.
Fig 2. Physical characterisation of alginate iron composites. (Ai) Low magnification STEM images of alginate-iron composites revealed the alginate
network ‘decorated’ in iron (denoted by arrows) with a single highly dense iron nucleation site (denoted with an asterisk). (Aii) A higher magnification image of
the nucleation centre revealed nanoparticles of approximately 2–5 nm in diameter. (B) Fast Fourier transform analysis of HAADF-STEM images of two
individual nanoparticles. (C) EDXmapping of iron-alginate composites with oxygen, iron and sodium localisation shown in the sample area. The copper from
the copper TEM grid functions as a control.
doi:10.1371/journal.pone.0138240.g002
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The effect of alginate on cellular iron metabolism
To assess the influence of alginate-iron interaction in human intestinal cells, RKO cells were
challenged with an iron-enriched media either with, or without alginate LFR5/60. The iron-
enriched media was spiked with radio-active iron-59, and after an incubation period of 24
hours the iron-content of the cell was measured (Fig 3A). Results demonstrated a significant
decrease (37%, p< 0.05) in radioactivity in cells co-cultured in the presence of alginate com-
pared to control (no alginate). To support this result ferritin expression, a surrogate marker for
cellular iron levels was also determined. Ferritin expression was significantly decreased (17
fold; p< 0.05) when cells were cultured in the presence of iron and alginate compared to iron
alone (control) (Fig 3B).
Alginate iron composites are not cell-permeable
Since alginate depleted intracellular iron, confocal microscopy was performed to assess the
localisation of the alginate in these cell culture experiments and specifically to deduce if the
alginate is internalised. To assess the bioavailability of alginate LFR5/60 and the composites
Fig 3. Effects of alginate on cellular iron transport. (A) Intracellular iron concentration decreases when RKO cells were incubated with iron-59 and
alginate (0.3% w/v) compared to iron only control (B) Treatment of RKO cells with iron increases ferritin expression whilst co-incubation with alginate (0.3%
w/v) significantly suppressed the iron mediated ferritin induction. All experiments were performed in triplicate with error bars representing +/- SEM and
* denotes statistical significance at p < 0.05.
doi:10.1371/journal.pone.0138240.g003
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formed upon interaction with iron a fluorescent analogue was prepared by conjugation with
fluoresceinamine (FITC) as schematically illustrated in Fig 4Ai. Absorption and emission spec-
tra were recorded for the fluorescent alginate with absorption and emission maxima (λmax) at
ca. 490 and 550 nm respectively (Fig 4B).
RKO cells were then cultured in the presence of FITC-alginate with or without a cellular
permeabilisation step for 24 hours on microscope slips which were subsequently used for imag-
ing in confocal microscopy. Cells were stained with DeepRed and Hoechst to define the cellular
membrane and nucleus respectively (Fig 5).
Confocal image analysis revealed that whilst there was negligible amounts of FITC-alginate
bound on the cell periphery (Fig 5B) no FITC-alginate was observed within the cell (Fig 5). As
a further control cells were membrane-permeabilised and co-cultured with FITC-alginate, and
in this instance, FITC- alginate is able to penetrate the outer cell membrane supporting the lim-
ited bioavailability of alginate in non-permeabilised cells.
Discussion
Alginates and their use in nanoparticle formation is well established, however this is the first
study to examine the interaction of iron and alginate in gastric-comparable pH conditions.
This is particularly warranted since the existing literature is inconsistent in terms of the effect
of alginate on cellular iron absorption and ultimate effects on human iron metabolism.[12,13]
Our results unequivocally demonstrate that alginate chelates iron under gastric comparable
conditions as evidenced through UV Visible spectroscopy, ITC and CD. We have found by
ITC that alginate–iron complexation involves two distinct binding events; an initial iron bind-
ing which then facilitates alginate reorganisation to accommodate the final iron binding. This
Fig 4. Synthesis of FITC alginate. (Ai) Reaction coupling scheme of FITC onto alginate under peptide coupling conditions. (Aii) Image of fluorescent
alginate in normal light (left) and exposed to λ = 365 nm UV light (right). (B) Absorption and emission (red and blue lines respectively) spectra of the
fluorescent alginate (FlAlg) product. The native alginate reactant has no absorption or emission profile, however, upon conjugation with FITC a highly
absorption and emission peaks are observed.
doi:10.1371/journal.pone.0138240.g004
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is consistent with previous studies which indicate cooperativity of metal binding to alginate. In
addition structural reorganisation of alginate polymers during ion binding has been reported
previously in the case of calcium. [24,25]
With regards to the species of iron that is complexed to alginate, UV Visible spectroscopy,
upon iron titration, revealed a peak at 280 nm which has previously been attributed to the pres-
ence of an iron-oxide species. This electronic transition is characteristic to the charge transfer
originating from the OH- ligands to the Fe ion.[26] CD Spectroscopy demonstrated that the
Fe-OH species were complexed to alginate since an induced CD signal was observed at 280
nm.
To probe the physical structure of the alginate iron composites formed under these physio-
logical conditions HAADF-STEM was utilised. Interestingly, we demonstrate that alginate che-
lates iron to form a range of composites, from long range gel-like structured strands to smaller
nanoparticulate matter. This mix of composites is unsurprising since the way the alginate and
iron is brought together is uncontrolled. The combination of solution spectroscopy and high
resolution STEM identified the core of the alginate nanoparticles to be iron-oxide in composi-
tion. However, it is known that the electron beam energy can affect samples under investigation
during examination in an electron microscope and thus it is important to note that there is the
possibility of electron beam damage causing structural and/or chemical particle-phase
Fig 5. Cellular localisation of alginate with confocal microscopy. Cells were treated with iron alone (control) or iron and FITC alginate with or without cell-
membrane permeabilisation. (A) Cells treated with iron alone as expected showed no FITC signal. (B) Cells treated with iron and FITC alginate showed
negligible punctate FITC staining on the cell periphery (C) Cells permeabilised with Saponin and then cultured with iron and FITC alginate showed an
abundance of intracellular FITC signal which was mostly cytoplasmic in localisation.
doi:10.1371/journal.pone.0138240.g005
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conversion. This could indeed result in a phase conversion from, for example, a ferrihydrite-
particle to a haematite arrangement, which were both found here.[27]
A mechanism of nanoparticle formation can be proposed whereby iron initially binds to
alginate forming an iron-hydroxide. Subsequently, at a critical concentration of iron loading,
the alginate collapses and forms a nucleation site where iron hydroxide condensation can take
place to form iron-oxide centred nanoparticles; the whole process templated by alginate (Fig
6). This mechanism supports the two event binding observed by ITC. Such models have been
reported for other biopolymers binding metals including carrageenans. [28]
These findings confirmed the iron-binding ability of alginate, with iron binding constants
on par with other biological proteins (e.g. ferritin), [29] and interestingly, ferritin similarly
stores iron as its oxide form.[29,30] The formation of these composites may rationalise some of
the effects seen in biological systems by others [12]. However, whilst it is clear that the alginate
binds iron, what effect this has on cellular and human iron metabolism remains controversial
whilst some studies advocating the usefulness of alginate in iron fortification and others iron
chelation programmes. [13,31,32]. Our data suggest that alginate has the potential to bind ‘free’
reactive iron and this leads to the formation of iron-oxide centred nanoparticles. Although
whether such ‘free’ iron exists within the gastrointestinal tract and or what form the residual
unabsorbed iron takes still remains to be elucidated; indeed, there is evidence supporting the
presence of both the particulate and ‘free’ forms.[33] Whether alginate is able bind particulate
iron, if it exists within the gastrointestinal tract is not known and this clearly warrants further
study.
From our own studies it is clear that alginate inhibits cellular iron transport by binding the
iron in solution and the resulting complex remaining extracellular. This is evidenced by a sup-
pression in cellular iron transport in the presence of alginate and a lack of any notable alginate
present within the cells.[11,34–36] We may hypothesise from these observations that the algi-
nate-iron nanoparticles are unable to be internalised into cells which may be due to a number
of factors including nanoparticle size and surface coating.
Thus it can be considered that alginates act as iron chelators and are not bioavailable with
respect to cellular uptake. This confirms previous studies, most notably, a recent human study
has shown that alginate supplementation inhibits iron absorption in man, [11,36] and this may
be attributed to the formation of iron-alginate nanoparticles. Thus in vivo alginate could be
considered as an iron chelator and coupled with its inherent non-absorbability would make it
Fig 6. Schematic illustration of the binding arrangement of iron to alginate under simple mixing conditions.
doi:10.1371/journal.pone.0138240.g006
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an ideal candidate for use in patients with inflammatory bowel disease and colorectal cancer
where excess reactive luminal iron is thought to be involved in the disease process.[37–39] One
might predict that alginate supplementation in these groups would enhance their health
through iron chelation.
Supporting Information
S1 Fig. ITC model of independent binding sites.Where Q = heat content of the solution,
n = number of binding sites, Mt = total concentration of macromolecule in Vo, Vo = active cell
volume, H = enthalpy, Xt = total ligand concentration and K = the binding constant.
(TIF)
S2 Fig. Equation of the 1:1 binding model.Where [H] = [alginate] and [G] = [Fe].
(TIF)
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